PACB
Price
$2.15
Change
+$0.32 (+17.49%)
Updated
Sep 30, 11:08 AM (EDT)
Capitalization
531.52M
42 days until earnings call
Intraday BUY SELL Signals
TXG
Price
$92.20
Change
+$2.17 (+2.41%)
Updated
Sep 30, 11:10 AM (EDT)
Capitalization
11.53B
35 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

PACB vs TXG

PACB vs TXG Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
PACB vs. TXG commentary
Sep 30, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PACB is a Buy and TXG is a Buy.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
PACB vs TXG: Fundamental Ratings
PACB
TXG
OUTLOOK RATING
1..100
3842
VALUATION
overvalued / fair valued / undervalued
1..100
99
Overvalued
44
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10093
PRICE GROWTH RATING
1..100
3834
P/E GROWTH RATING
1..100
64100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TXG's Valuation (44) in the null industry is somewhat better than the same rating for PACB (99) in the Biotechnology industry. This means that TXG’s stock grew somewhat faster than PACB’s over the last 12 months.

TXG's Profit vs Risk Rating (100) in the null industry is in the same range as PACB (100) in the Biotechnology industry. This means that TXG’s stock grew similarly to PACB’s over the last 12 months.

TXG's SMR Rating (93) in the null industry is in the same range as PACB (100) in the Biotechnology industry. This means that TXG’s stock grew similarly to PACB’s over the last 12 months.

TXG's Price Growth Rating (34) in the null industry is in the same range as PACB (38) in the Biotechnology industry. This means that TXG’s stock grew similarly to PACB’s over the last 12 months.

PACB's P/E Growth Rating (64) in the Biotechnology industry is somewhat better than the same rating for TXG (100) in the null industry. This means that PACB’s stock grew somewhat faster than TXG’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PACBTXG
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
76%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
74%
Momentum
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
81%
MACD
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
69%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
78%
Declines
ODDS (%)
Bearish Trend 10 days ago
89%
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
81%
COMPARISON
Comparison
Sep 30, 2026
Stock price -- (PACB: $1.83 vs. TXG: $90.04)
Brand notoriety: PACB and TXG are both not notable
Both companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: PACB: 214% vs. TXG: 122%
Market capitalization -- PACB: $531.52M vs. TXG: $11.53B
PACB [@Medical/Nursing Services] is valued at $531.52M. TXG’s [@Medical/Nursing Services] market capitalization is $11.53B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $837 to $174.73B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.55B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PACB’s FA Score shows that 0 FA rating(s) are green while TXG’s FA Score has 0 green FA rating(s).

  • PACB’s FA Score: 0 green, 5 red.
  • TXG’s FA Score: 0 green, 5 red.
According to our system of comparison, TXG is a better buy in the long-term than PACB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PACB’s TA Score shows that 5 TA indicator(s) are bullish while TXG’s TA Score has 4 bullish TA indicator(s).

  • PACB’s TA Score: 5 bullish, 4 bearish.
  • TXG’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, both PACB and TXG are a good buy in the short-term.

Price Growth

PACB (@Medical/Nursing Services) experienced а +24.49% price change this week, while TXG (@Medical/Nursing Services) price change was +11.57% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -1.42%. For the same industry, the average monthly price growth was -6.24%, and the average quarterly price growth was -1.57%.

Reported Earning Dates

PACB is expected to report earnings on Nov 11, 2026.

TXG is expected to report earnings on Nov 04, 2026.

Industries' Descriptions

@Medical/Nursing Services (-1.42% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

View a ticker or compare two or three
PACB
Daily Signal:
Gain/Loss:
TXG
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
COTY2.690.01
+0.37%
COTY
PAC210.41-3.41
-1.59%
Grupo Aeroportuario del Pacifico SAB de CV Amer Dep Shares (each rep 10 Ser B shares)
CIX37.77-1.14
-2.93%
Comp X International
CYCU2.65-0.12
-4.33%
Cycurion Inc
EDVA0.18-0.01
-5.46%
Endovia Health Sciences Inc

PACB and

Correlation & Price change

A.I.dvisor indicates that over the last year, PACB has been loosely correlated with TXG. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if PACB jumps, then TXG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PACB
1D Price
Change %
PACB100%
+7.02%
TXG - PACB
56%
Loosely correlated
+1.74%
QSI - PACB
54%
Loosely correlated
+20.52%
BFLY - PACB
52%
Loosely correlated
-0.55%
ILMN - PACB
48%
Loosely correlated
+0.04%
AZTA - PACB
45%
Loosely correlated
+0.09%
More

TXG and

Correlation & Price change

A.I.dvisor indicates that over the last year, TXG has been loosely correlated with COIN. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if TXG jumps, then COIN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TXG
1D Price
Change %
TXG100%
+1.74%
COIN - TXG
56%
Loosely correlated
-0.92%
PACB - TXG
56%
Loosely correlated
+7.02%
BRKR - TXG
54%
Loosely correlated
+1.94%
CLSK - TXG
54%
Loosely correlated
-0.22%
RIOT - TXG
54%
Loosely correlated
-1.06%
More